CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.
about
Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingMultidimensional Roles of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in Malignant CancersWnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker.Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumorsHigh expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling.A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers.microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancerIdentifying key stage-specific genes and transcription factors for gastric cancer based on RNA-sequencing dataTreatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumorsSP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma.Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma.Collagen triple helix repeat containing 1 promotes tumor angiogenesis in gastrointestinal stromal tumors.CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.An integrated analysis of genome‐wide DNA methylation and gene expression data in hepatocellular carcinoma.Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma
P2860
Q26861795-A0814058-C073-4C98-8538-8D2526C8DF30Q28075715-97CC0532-2B61-46B8-9597-8E10840EDB85Q33761857-4F69A4C9-AAB8-4BB0-AD83-D386B9DF643BQ33779687-A2D5D5A9-D601-459D-AA25-6A7B62308ADCQ33827629-A8DD776A-C799-493C-987B-892A1FFD46D0Q33891101-23ECCC48-0A74-4D74-B984-BE53B596074DQ35150412-93514601-BD28-4FC8-89EC-02B10EAC7EC7Q36070655-2A6DE74F-45B1-4F37-8E46-0038FF1C0DEFQ36259615-7374C86C-3FA2-4138-A91D-CA40DDB1EC42Q36279532-130C3F59-9324-45A6-A915-D8C52478AE54Q36323136-08D3E739-8747-4A50-8A5D-20994D7A5890Q36546475-499ED423-CEDB-4685-B643-F4453906D380Q37012394-BCEBF42D-DA5A-4561-AB8C-5301E30B0FD3Q37046800-866B369F-3AF5-4C84-8EDE-F508DBBA812CQ37310265-773BB579-DD2D-48C3-9C13-380D49CF1437Q38992689-858826E5-FBEE-4A18-8D83-545B1B2CC646Q39100241-95F4F7DF-806A-410B-A60E-C0132EBCF3C7Q41105900-EB11CB47-221D-46EF-B984-67926BCA2D3EQ47113933-B16B0858-398D-424C-8101-91C365EF6867Q48533249-5DF6AB34-02C4-4D08-898F-8BA367822F74Q52598238-19D6469B-285E-4B13-96AC-BDF7622DFDB2Q54982215-944EDEB7-E63C-4E76-9918-590D213E3257Q55453653-46A22E1F-CA77-45DA-B65C-426269481DD5Q58792261-3D283994-A02C-4395-A996-A4FB3C144B91
P2860
CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@ast
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@en
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@nl
type
label
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@ast
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@en
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@nl
prefLabel
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@ast
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@en
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@nl
P2093
P2860
P1433
P1476
CTHRC1 is upregulated by promo ...... tasis in human gastric cancer.
@en
P2093
Jing-De Zhu
Jing-Yuan Fang
Xiao-Yu Chen
Yan-Jie Zhang
Ying-Chao Wang
You-Yong Lu
Zhi-Yong Shen
P2860
P304
P356
10.1111/J.1349-7006.2012.02292.X
P577
2012-05-17T00:00:00Z